
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Screening Rates for Primary Aldosteronism in Resistant Hypertension
Gilad Jaffe, Zachary Gray, Gomathi Krishnan, et al.
Hypertension (2020) Vol. 75, Iss. 3, pp. 650-659
Open Access | Times Cited: 126
Gilad Jaffe, Zachary Gray, Gomathi Krishnan, et al.
Hypertension (2020) Vol. 75, Iss. 3, pp. 650-659
Open Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
The Unrecognized Prevalence of Primary Aldosteronism
Jenifer M. Brown, Mohammed Siddiqui, David A. Calhoun, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 1, pp. 10-20
Open Access | Times Cited: 427
Jenifer M. Brown, Mohammed Siddiqui, David A. Calhoun, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 1, pp. 10-20
Open Access | Times Cited: 427
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
John W. McEvoy, Cian P. McCarthy, Rosa María Bruno, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 322
Primary aldosteronism — a multidimensional syndrome
Adina F. Turcu, Jun Yang, Anand Vaidya
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 11, pp. 665-682
Closed Access | Times Cited: 82
Adina F. Turcu, Jun Yang, Anand Vaidya
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 11, pp. 665-682
Closed Access | Times Cited: 82
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans
Jordana B. Cohen, Debbie L. Cohen, Daniel S. Herman, et al.
Annals of Internal Medicine (2020) Vol. 174, Iss. 3, pp. 289-297
Open Access | Times Cited: 119
Jordana B. Cohen, Debbie L. Cohen, Daniel S. Herman, et al.
Annals of Internal Medicine (2020) Vol. 174, Iss. 3, pp. 289-297
Open Access | Times Cited: 119
Evolution of the Primary Aldosteronism Syndrome: Updating the Approach
Anand Vaidya, Robert M. Carey
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3771-3783
Open Access | Times Cited: 106
Anand Vaidya, Robert M. Carey
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 12, pp. 3771-3783
Open Access | Times Cited: 106
Guideline-Driven Management of Hypertension
Robert M. Carey, Jackson T. Wright, Sandra J. Taler, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 827-846
Open Access | Times Cited: 99
Robert M. Carey, Jackson T. Wright, Sandra J. Taler, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 827-846
Open Access | Times Cited: 99
Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism
Nicholas Yozamp, Gregory L. Hundemer, Marwan Moussa, et al.
Hypertension (2020) Vol. 77, Iss. 3, pp. 891-899
Open Access | Times Cited: 74
Nicholas Yozamp, Gregory L. Hundemer, Marwan Moussa, et al.
Hypertension (2020) Vol. 77, Iss. 3, pp. 891-899
Open Access | Times Cited: 74
Genetics of Primary Aldosteronism
Ute I. Scholl
Hypertension (2022) Vol. 79, Iss. 5, pp. 887-897
Open Access | Times Cited: 65
Ute I. Scholl
Hypertension (2022) Vol. 79, Iss. 5, pp. 887-897
Open Access | Times Cited: 65
Primary Aldosteronism: State-of-the-Art Review
Anand Vaidya, Gregory L. Hundemer, Kazutaka Nanba, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 967-988
Open Access | Times Cited: 65
Anand Vaidya, Gregory L. Hundemer, Kazutaka Nanba, et al.
American Journal of Hypertension (2022) Vol. 35, Iss. 12, pp. 967-988
Open Access | Times Cited: 65
The Role of Aldosterone in OSA and OSA-Related Hypertension
Yi Wang, Chuan Xiang Li, Ying Ni Lin, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 42
Yi Wang, Chuan Xiang Li, Ying Ni Lin, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 42
The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis
James M. Luther, Agnes B. Fogo
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 63-68
Open Access | Times Cited: 42
James M. Luther, Agnes B. Fogo
Kidney International Supplements (2022) Vol. 12, Iss. 1, pp. 63-68
Open Access | Times Cited: 42
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Gregory L. Hundemer, Alexander A. C. Leung, Gregory Kline, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 69-94
Open Access | Times Cited: 29
Gregory L. Hundemer, Alexander A. C. Leung, Gregory Kline, et al.
Endocrine Reviews (2023) Vol. 45, Iss. 1, pp. 69-94
Open Access | Times Cited: 29
Evaluation of a Best-Practice Advisory for Primary Aldosteronism Screening
Suranut Charoensri, Linda Bashaw, Cheryl Dehmlow, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 2, pp. 174-174
Closed Access | Times Cited: 12
Suranut Charoensri, Linda Bashaw, Cheryl Dehmlow, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 2, pp. 174-174
Closed Access | Times Cited: 12
Diagnosis and management of resistant hypertension
Ernesto L. Schiffrin, Naomi D.L. Fisher
BMJ (2024), pp. e079108-e079108
Open Access | Times Cited: 12
Ernesto L. Schiffrin, Naomi D.L. Fisher
BMJ (2024), pp. e079108-e079108
Open Access | Times Cited: 12
Screening Rates for Primary Aldosteronism Among Individuals With Hypertension Plus Hypokalemia: A Population-Based Retrospective Cohort Study
Gregory L. Hundemer, Haris Imsirovic, Anand Vaidya, et al.
Hypertension (2021) Vol. 79, Iss. 1, pp. 178-186
Open Access | Times Cited: 56
Gregory L. Hundemer, Haris Imsirovic, Anand Vaidya, et al.
Hypertension (2021) Vol. 79, Iss. 1, pp. 178-186
Open Access | Times Cited: 56
Outcomes of a Specialized Clinic on Rates of Investigation and Treatment of Primary Aldosteronism
Yuan-yuan Liu, James A. King, Gregory Kline, et al.
JAMA Surgery (2021) Vol. 156, Iss. 6, pp. 541-541
Open Access | Times Cited: 47
Yuan-yuan Liu, James A. King, Gregory Kline, et al.
JAMA Surgery (2021) Vol. 156, Iss. 6, pp. 541-541
Open Access | Times Cited: 47
Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities
Adina F. Turcu, Winnie Nhan, Seda Grigoryan, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 14
Open Access | Times Cited: 30
Adina F. Turcu, Winnie Nhan, Seda Grigoryan, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 14
Open Access | Times Cited: 30
Performance of Aldosterone-to-renin Ratio Before Washout of Antihypertensive Drugs in Screening of Primary Aldosteronism
X. Liu, Sufang Hao, Jin‐Song Bian, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2302-e2308
Open Access | Times Cited: 7
X. Liu, Sufang Hao, Jin‐Song Bian, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 12, pp. e2302-e2308
Open Access | Times Cited: 7
Renal denervation in hypertension patients: Proceedings from an expert consensus roundtable cosponsored by SCAI and NKF
David E. Kandzari, Raymond R. Townsend, George L. Bakris, et al.
Catheterization and Cardiovascular Interventions (2021) Vol. 98, Iss. 3, pp. 416-426
Open Access | Times Cited: 35
David E. Kandzari, Raymond R. Townsend, George L. Bakris, et al.
Catheterization and Cardiovascular Interventions (2021) Vol. 98, Iss. 3, pp. 416-426
Open Access | Times Cited: 35
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Xiao Lin, Muhammad Hasnain Ehsan Ullah, Wu Xiong, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Xiao Lin, Muhammad Hasnain Ehsan Ullah, Wu Xiong, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Recalibrating Interpretations of Aldosterone Assays Across the Physiologic Range: Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry Measurements Under Multiple Controlled Conditions
Jenifer M. Brown, Richard J. Auchus, Brooke Honzel, et al.
Journal of the Endocrine Society (2022) Vol. 6, Iss. 6
Open Access | Times Cited: 23
Jenifer M. Brown, Richard J. Auchus, Brooke Honzel, et al.
Journal of the Endocrine Society (2022) Vol. 6, Iss. 6
Open Access | Times Cited: 23
Primary aldosteronism and pregnancy
V.І. Medved, M.Yе. Kyrylchuk, A.Ye. Husieva
Reproductive Endocrinology (2022), Iss. 63-64, pp. 39-46
Open Access | Times Cited: 23
V.І. Medved, M.Yе. Kyrylchuk, A.Ye. Husieva
Reproductive Endocrinology (2022), Iss. 63-64, pp. 39-46
Open Access | Times Cited: 23
Aldosterone and aldosterone synthase inhibitors in cardiorenal disease
Subodh Verma, Avinash Pandey, Arjun Pandey, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 3, pp. H670-H688
Closed Access | Times Cited: 15
Subodh Verma, Avinash Pandey, Arjun Pandey, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 326, Iss. 3, pp. H670-H688
Closed Access | Times Cited: 15
Resistant hypertension: Diagnosis, evaluation, and treatment practical approach
Roberto Parodi, Laura Brandani, César Romero, et al.
European Journal of Internal Medicine (2024) Vol. 123, pp. 23-28
Closed Access | Times Cited: 6
Roberto Parodi, Laura Brandani, César Romero, et al.
European Journal of Internal Medicine (2024) Vol. 123, pp. 23-28
Closed Access | Times Cited: 6
Dietary sodium alters aldosterone's effect on renal sodium transporter expression and distal convoluted tubule remodelling
Stephanie M. Mutchler, Mahpara Hasan, Carolyn P. Murphy, et al.
The Journal of Physiology (2024) Vol. 602, Iss. 5, pp. 967-987
Closed Access | Times Cited: 5
Stephanie M. Mutchler, Mahpara Hasan, Carolyn P. Murphy, et al.
The Journal of Physiology (2024) Vol. 602, Iss. 5, pp. 967-987
Closed Access | Times Cited: 5